Cardiff Oncology, Inc.

CRDF · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$51,470$21,655$16,347$11,943
Short-Term Investments$40,276$53,168$88,920$128,878
Receivables$773$288$771$535
Inventory$0$0$0$0
Other Curr. Assets$2,535$2,301$5,246$4,771
Total Curr. Assets$95,054$77,412$111,284$146,127
Property Plant & Equip (Net)$2,067$2,946$3,520$3,178
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$69$1,279$1,387$239
Total NC Assets$2,136$4,225$4,907$3,417
Other Assets$0$0$0$0
Total Assets$97,190$81,637$116,191$149,544
Liabilities
Payables$4,821$1,966$1,956$1,439
Short-Term Debt$710$691$675$551
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$7,897$7,783$5,177$4,569
Total Curr. Liab.$13,428$10,440$7,808$6,559
LT Debt$813$1,458$2,040$2,568
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$813$1,458$2,040$2,568
Other Liabilities$0$0$0$0
Cap. Leases$1,523$2,149$2,715$3,119
Total Liabilities$14,241$11,898$9,848$9,127
Equity
Pref Stock$0$0$0$1
Common Stock$7$4$4$4
Retained Earnings-$384,179-$339,541-$298,100-$259,810
AOCI$34-$67-$395-$142
Other Equity$467,087$409,343$404,834$400,364
Total Equity$82,949$69,739$106,343$140,417
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$97,190$81,637$116,191$149,544
Net Debt-$49,947-$19,506-$13,632-$8,824